Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;186(3):e24-e27.
doi: 10.1111/bjh.15859. Epub 2019 Mar 11.

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

Fredrik Ellin  1 , Matthew J Maurer  2 , Line Srour  3   4 , Umar Farooq  5 , Mats Jerkeman  1 , Joseph M Connors  6 , Karin E Smedby  7 , N Nora Bennani  8 , Stephen M Ansell  8 , Graham W Slack  9 , James R Cerhan  2 , Thomas Relander  1 , Andrew L Feldman  10 , Kerry J Savage  6
Affiliations

Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas

Fredrik Ellin et al. Br J Haematol. 2019 Aug.
No abstract available

Keywords: IPI; PIT; NCCN-IPI; peripheral T-cell lymphoma; prognostic factors.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

None of the authors reported any conflicts of interest. The work was funded through grants P50 CA97274 and U01 CA195568.

Figures

Figure 1.
Figure 1.
Overall Survival according to NCCN-IPI, IPI and PIT in AITL (A-C), PTCL NOS (D-F) and ALK- ALCL (G-I). Colours represent low (black), low-intermediate (red), high- intermediate (green) and high (blue) risk groups. In AITL grouped according to NCCN-IPI (panel A), no events occurred in the low risk group. AITL, Angioimmunoblastic T-cell lymphoma; ALK- ALCL, anaplastic lymphoma kinase-negative anaplastic large cell lymphoma; IPI, International prognostic index; NCCN, National Comprehensive Cancer Network; PIT, Prognostic Index for T-cell lymphoma; PTCL NOS, Peripheral T-cell lymphoma not otherwise specified
See this image and copyright information in PMC

References

    1. Ansell SM, Habermann TM, Kurtin PJ, Witzig TE, Chen MG, Li CY, Inwards DJ & Colgan JP. (1997) Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. Journal of Clinical Oncology, 15, 2296–2301. - PubMed
    1. Ellin F, Landstrom J, Jerkeman M & Relander T. (2014) Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry. Blood, 124, 1570–1577. - PubMed
    1. Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B,Harris NL, Jaffe ES, Pileri SA, Savage KJ, Weisenburger DD, Armitage JO, Mounier N & Vose JM. (2012) Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. Journal of Clinical Oncology, 31, 240–246. - PMC - PubMed
    1. Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, Morabito F, Martelli M, Brusamolini E, Iannito E, Zaja F, Cortelazzo S, Rigacci L, Devizzi L, Todeschini G, Santini G, Brugiatelli M & Federico M. (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood, 103, 2474–2479. - PubMed
    1. Mourad N, Mounier N, Briere J, Raffoux E, Delmer A, Feller A, Meijer CJLM, Emile J-F, Bouabdallah R, Bosly A, Diebold J, Haioun C, Coiffier B, Gisselbrecht C & Gaulard P. (2008) Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d’Etude des Lymphomes de l’Adulte (GELA) trials. Blood, 111, 4463–4470. - PMC - PubMed

Publication types